Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital

Table 5 Antimicrobial resistance of Enterococcus and Staphylococcus isolates to the tested antibiotics

Resistance rate (%)
Isolate/Antibiotics	2008–2011	2012–2015	Total	P for Trend Test
Enterococcus
AMP	72.22	92.45	84.27	0.01
STH	47.06	57.58	52.24	0.389
GEH	71.74	79.25	75.76	0.385
ERY	88.57	88.68	88.64	0.988
CIP	89.29	90.57	90.12	0.854
CLI	100.00	95.56	95.92	0.667
MFX	63.64	91.11	85.71	0.02
PEN	87.23	92.31	89.90	0.403
TCY	74.29	69.23	71.26	0.609
VAN	4.26	9.43	7.00	0.311
LNZ	4.88	0.00	2.17	0.111
LVX	77.14	90.38	85.06	0.089
Staphylococcus
OXA	82.69	93.10	86.42	0.190
SXT	47.62	24.14	38.03	0.045
ERY	84.62	82.76	83.95	0.827
CIP	73.68	89.66	83.33	0.147
CLI	69.57	57.14	64.86	0.278
MFX	46.34	37.93	42.86	0.484
PEN	94.34	100.00	96.34	0.192
GEN	71.15	72.41	71.60	0.904
TCY	56.82	68.97	61.64	0.296
VAN	0.00	0.00	0.00	–
LNZ	0.00	0.00	0.00	–
LVX	68.89	79.31	72.97	0.324
Not all tested antibiotics are listed

AMP Ampicillin, OXA Oxacillin, STH Streptomycin-High, SXT Trimethoprim/Sulfamethoxazole, ERY erythromycin, GEH gentamicin, CIP ciprofloxacin, CLI Clindamycin, MFX moxifloxacin, PEN penicillin, TCY tetracycline, VAN Vancomycin, LNZ Linezolid, LVX Levofloxacin
Data in boldface reflected p values < 0.05

ISSN: 1471-2334